- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Fuzhou University
Total 222137 results
-
Xuzhou Central HospitalRecruitingPostoperative DeliriumChina
-
Suzhou Municipal HospitalRecruiting
-
Xuzhou Central HospitalEnrolling by invitation
-
Xuzhou Central HospitalUnknown
-
Xuzhou Central HospitalTerminatedRectal Cancer | Colonic CancerChina
-
Xuzhou Central HospitalCompletedHepatocellular Carcinoma | Cholangiocarcinoma | Gallbladder CarcinomaChina
-
Suzhou Landing PharmaceuticalsCompleted
-
Han YuanCompletedPostoperative Chronic CoughChina
-
Han YuanCompletedPostoperative Cognitive DysfunctionChina
-
Han YuanUnknown
-
PersonGen BioTherapeutics (Suzhou) Co., Ltd.Second Affiliated Hospital of Suzhou UniversityUnknown
-
Fuzhou HuaRecruitingPostoperative Delirium | Postoperative Cognitive Dysfunction | Perioperative Period | AnestheticChina
-
Guizhou Medical UniversityRecruitingProphylactic Cranial Irradiation, Cumulative Incidence of Brain MetastasesChina
-
Guizhou Medical UniversityUnknownRadiotherapy | Nonsmall Cell Lung Cancer, Stage IVChina
-
Guizhou Medical UniversityUnknown
-
Guizhou Medical UniversityUnknownSmall-cell Lung CancerChina
-
Guizhou Medical UniversityRecruiting
-
Guizhou Medical UniversityNot yet recruitingNon-small Cell Lung Cancer
-
Guizhou Medical UniversityUnknownMalignant Pleural Effusion | Nonsmall Cell Lung Cancer, Stage IVChina
-
Guizhou Medical UniversityNot yet recruitingStage IV Non-small Cell Lung Cancer
-
Guizhou Medical UniversityEnrolling by invitationRadiotherapy; ComplicationsChina
-
Jin Dong LiuUnknown
-
Ignis Therapeutics (Suzhou) LimitedRecruitingExcessive Daytime Sleepiness Associated With Obstructive Sleep ApneaChina
-
Elpiscience (Suzhou) Biopharma, Ltd.RecruitingSolid Tumor | Metastatic Solid Tumor | Locally Advanced Solid TumorChina
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerUnited States
-
People's Hospital of QuzhouRecruiting
-
Suzhou Zanrong Pharma LimitedRecruitingAdvanced Solid Tumors | HER2-positive Breast CancerChina
-
Suzhou Connect Biopharmaceuticals, Ltd.Active, not recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedHealthy Adult SubjectsChina
-
Suzhou Connect Biopharmaceuticals, Ltd.TerminatedChronic Rhinosinusitis With Nasal PolypsUnited States, China, Poland, Spain, Ukraine
-
Suzhou Kintor Pharmaceutical Inc,TerminatedCovid19United States, China, Philippines, South Africa, Ukraine
-
Suzhou Kintor Pharmaceutical Inc,Completed
-
Suzhou Connect Biopharmaceuticals, Ltd.Completed
-
Suzhou Kintor Pharmaceutical Inc,Completed
-
Xuzhou Third People's HospitalUnknownLeft Main Coronary Artery Disease | Bifurcation Lesions | Coronary DiseasesChina
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
SuZhou Stainwei Biotech Inc.Unknown
-
The Affiliated Hospital of Xuzhou Medical UniversityXuzhou Medical University; IIT MediTech Co. LtdRecruiting
-
Xuzhou Medical UniversityYake Biotechnology Ltd.Recruiting
-
ZHANG Qing-huaActive, not recruiting
-
Suzhou Alphamab Co., Ltd.RecruitingHemophilia A With Inhibitor | Hemophilia B With InhibitorChina
-
Suzhou Alphamab Co., Ltd.RecruitingKnee Arthroplasty, TotalChina
-
Suzhou Alphamab Co., Ltd.Recruiting
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Ulcerative ColitisUnited States, China, Pakistan, Ukraine
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate-to-severe Atopic DermatitisChina
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Persistent AsthmaUnited States, China, Hungary, Korea, Republic of, Poland
-
Suzhou Kintor Pharmaceutical Inc,CompletedMetastatic Hormone-Sensitive Prostate Cancer (mHSPC) | Metastatic Castrate Resistant Prostate Cancer (mCRPC)United States
-
Suzhou Kintor Pharmaceutical Inc,CompletedHCC | Metastatic Hepatocellular Carcinoma | Combinations of Drugs; DependenceTaiwan
-
Suzhou Kintor Pharmaceutical Inc,CompletedEfficacy and SafetyUnited States
-
Suzhou Kintor Pharmaceutical Inc,CompletedTo Evaluate Efficacy, Safety, and Tolerability of KX-826 in Male Subjects With Androgenetic AlopeciaAlopecia | Male Pattern Hair LossUnited States